Suppression of HIV-Specific and Allogeneic T Cell Activation by Human Regulatory T Cells Is Dependent on the Strength of Signals

被引:15
作者
Antons, Amanda K. [1 ]
Wang, Rui [3 ]
Kalams, Spyros A. [1 ,2 ]
Unutmaz, Derya [3 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA
[3] NYU, Sch Med, Dept Microbiol, New York, NY USA
来源
PLOS ONE | 2008年 / 3卷 / 08期
基金
美国国家卫生研究院;
关键词
D O I
10.1371/journal.pone.0002952
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Regulatory T cells (Tregs) suppress immune responses against both self and non-self antigens. Tregs require activation through the T cell receptor (TCR) and IL-2 to exert their suppressive functions. However, how strength of TCR signals modulate the potency of Treg-mediated suppression of antigen-specific T cell activation remain unclear. We found that both strength of TCR signals and ratios of Tregs to target cells, either through superantigen, allogeneic antigens or HIV-specific peptides, modified the suppressive ability of Tregs. While human Tregs were able to mediate suppression in the presence of only autologous antigen-presenting cells, this was much less efficient as compared to when Tregs were activated by allogeneic dendritic cells. In another physiologically relevant system, we show that the strength of peptide stimulation, high frequency of responder CD8+ T cells or presence of high IL-2 can override the suppression of HIV-specific CD8+ T cells by Tregs. These findings suggest that ratios and TCR activation of human Tregs, are important parameters to overcome robust immune responses to pathogens or allogeneic antigens. Modulating the strength of T cell signals and selective enhancement or depletion of antigen-specific Tregs thus may have implications for designing potent vaccines and regulating immune responses during allogeneic transplantation and chronic infections.
引用
收藏
页数:8
相关论文
共 56 条
[1]   Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens [J].
Aandahl, EM ;
Michaëlsson, J ;
Moretto, WJ ;
Hecht, FA ;
Nixon, DF .
JOURNAL OF VIROLOGY, 2004, 78 (05) :2454-2459
[2]   Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible HIV infection [J].
Antons, Amanda K. ;
Wang, Rui ;
Oswald-Richter, Kyra ;
Tseng, Michelle ;
Arendt, Christopher W. ;
Kalams, Spyros A. ;
Unutmaz, Derya .
JOURNAL OF IMMUNOLOGY, 2008, 180 (02) :764-773
[3]   The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells [J].
Aseffa, A ;
Gumy, A ;
Launois, P ;
MacDonald, HR ;
Louis, JA ;
Tacchini-Cottier, F .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3232-3241
[4]   Cell-surface IL-7 receptor expression facilitates the purification of FOXP3+ regulatory T cells [J].
Banham, Alison H. .
TRENDS IN IMMUNOLOGY, 2006, 27 (12) :541-544
[5]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[6]   IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena [J].
Bennett, CL ;
Ochs, HD .
CURRENT OPINION IN PEDIATRICS, 2001, 13 (06) :533-538
[7]   Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse [J].
Brunkow, ME ;
Jeffery, EW ;
Hjerrild, KA ;
Paeper, B ;
Clark, LB ;
Yasayko, SA ;
Wilkinson, JE ;
Galas, D ;
Ziegler, SF ;
Ramsdell, F .
NATURE GENETICS, 2001, 27 (01) :68-73
[8]   Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage [J].
Cabarrocas, Julie ;
Cassan, Cecile ;
Magnusson, Fay ;
Piaggio, Eliane ;
Mars, Lennart ;
Derbinski, Jens ;
Kyewski, Bruno ;
Gross, David-Alexandre ;
Salomon, Benoit L. ;
Khazaie, Khashayarsha ;
Saoudi, Abdelhadi ;
Liblau, Roland S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (22) :8453-8458
[9]   DETECTION OF 3 DISTINCT PATTERNS OF T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS - INDEPENDENCE OF CD4+ CELL NUMBERS AND CLINICAL STAGING [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
LUCEY, DR ;
VIA, CS ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1892-1899
[10]   CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].
Cohen, JL ;
Trenado, A ;
Vasey, D ;
Klatzmann, D ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406